Log in to save to my catalogue

QuantiFERON-TB Gold Plus for screening and monitoring latent tuberculosis infection in spondyloarthr...

QuantiFERON-TB Gold Plus for screening and monitoring latent tuberculosis infection in spondyloarthr...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_615908e8204f47c79d7cd5045b4a412c

QuantiFERON-TB Gold Plus for screening and monitoring latent tuberculosis infection in spondyloarthritis patients

About this item

Full title

QuantiFERON-TB Gold Plus for screening and monitoring latent tuberculosis infection in spondyloarthritis patients

Publisher

Italy: The Journal of Infection in Developing Countries

Journal title

Journal of infection in developing countries, 2025-05, Vol.19 (5), p.739

Language

English

Formats

Publication information

Publisher

Italy: The Journal of Infection in Developing Countries

More information

Scope and Contents

Contents

The optimal frequency of rescreening for latent tuberculosis infection (LTBI) in patients with inflammatory arthritis on biologic/targeted-synthetic disease modifying anti-rheumatic drugs (b/ts-DMARDs) is uncertain. We aimed to evaluate the impact of LTBI re-screening using the QuantiFERON-TB Gold Plus (QFT-Plus; QIAGEN, Germantown, USA) test metho...

Alternative Titles

Full title

QuantiFERON-TB Gold Plus for screening and monitoring latent tuberculosis infection in spondyloarthritis patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_615908e8204f47c79d7cd5045b4a412c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_615908e8204f47c79d7cd5045b4a412c

Other Identifiers

ISSN

1972-2680

E-ISSN

1972-2680

DOI

10.3855/jidc.21027

How to access this item